AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM

NCT05100641 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

672

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Glioblastoma

Interventions

BIOLOGICAL: AV-GBM-1
BIOLOGICAL: Autologous monocytes

Sponsor

Aivita Biomedical, Inc.